Humanized antibodies that sequester amyloid beta peptide

Details for Australian Patent Application No. 2006249277 (hide)

Owner Washington University Eli Lilly and Company

Inventors Demattos, Ronald; Paul, Steven M.; Vasquez, Maximiliano; Tsurushita, Naoya; Bales, Kelly R; Holtzman, David M.

Agent Spruson & Ferguson

Pub. Number AU-B-2006249277

Parent 2001241786

Filing date 8 December 2006

Wipo publication date 4 January 2007

Acceptance publication date 13 May 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12R 1/91 (2006.01)

Event Publications

4 January 2007 Application Open to Public Inspection

  Published as AU-B-2006249277

4 January 2007 Complete Application Filed

13 May 2010 Application Accepted

  Published as AU-B-2006249277

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249278-Flush tank drain valve assembly

2006249276-Peripheral device, playing time measuring system and playing time measuring device